Baumer S.A. (BALM4.SA)

Baumer S.A. (BALM4.SA) — VMCI valuation read

Baumer S.A. sits at VMCI 67/100, with the Healthcare sector median at 50. That 17-point spread is the first thing to note on BALM4.SA: it tells the reader the composite is favorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on BALM4.SA are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on BALM4.SA: BALM4.SA trades at 20.0x earnings, 11% above the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 12.0% sits 2.0pp above the Healthcare median (10.0%). The Risk read: net debt to EBITDA of 3.3x is the binding constraint on the bear case, anchoring the bear scenario on a measurable balance-sheet metric.

BALM4.SA rose 0.1% over the trailing 7 days, with a -13.8% read on a 30-day basis.